The Motley Fool: Can Perrigo Company PLC Continue Its Bull Run?

There's a pretty good chance that if you use store-brand OTC consumer health products, you have a Perrigo (NYSE: PRGO  ) product in your bathroom right now. Perrigo hasn't completely eschewed the prescription-based generic drug business that build companies like Teva (NYSE: TEVA  ) , but it has focused a great deal of its time and energy on ruling the store-brand OTC market. That business now offers pretty solid cash flow and returns, with plenty of growth opportunity in areas like diabetes and pet care. Perrigo doesn't exactly carry a "store-brand" multiple today, but these shares could still offer some upside as the company looks forward to further OTC launches, additional M&A, and growth in the nutrition and overseas markets.

Read more here:
Can Perrigo Company PLC Continue Its Bull Run?

Bye Bye NBTY

Even the wildest rollercoaster rides come to an end, and nutritional supplement maker NBTY's (NYSE:NTY) ride is at an end. Before the open Thursday, NTY announced that the company had accepted a $3.5 billion all-cash buyout offer from private equity giant Carlyle Group. 

If you have never paid much attention to NBTY before, pull up a long term chart and count the number of 50% retracements over the past 20 years - I think I counted seven. I have followed this stock for at least 15 of those years, and owned it once along the way. Throughout that run, I was always surprised that the company could never carve out a steady and stable growth trajectory. 


To read the full piece, please go to:
http://stocks.investopedia.com/stock-analysis/2010/Bye-Bye-NBTY-NTY-PRGO-BAC-BX-BCS0719.aspx